F. Rivera

A. Carrato3
P. Jimenez-Fonseca2
J. L. Manzano2
C. Pericay2
C. García-Girón2
3A. Carrato
2P. Jimenez-Fonseca
2J. L. Manzano
2C. Pericay
2C. García-Girón
Learn More
  • Eduardo Díaz-Rubio, Auxiliadora Gómez-España, Bartomeu Massutí, Javier Sastre, Margarita Reboredo, José Luis Manzano +65 others
  • 2012
BACKGROUND In the MACRO study, patients with metastatic colorectal cancer (mCRC) were randomised to first-line treatment with 6 cycles of capecitabine and oxaliplatin (XELOX) plus bevacizumab followed by either single-agent bevacizumab or XELOX plus bevacizumab until disease progression. An additional retrospective analysis was performed to define the(More)
Gastric cancer is the fourth cause of death by cancer in Spain and a significant medical problem. Molecular biology results evidence that gastroesophageal junction tumors and gastric cancer should be considered as two independent entities with a different prognosis and treatment approach. Endoscopic resection in very early tumors is feasible. Neoadjuvant(More)
REVERIE – REal and Virtual Engagement in Realistic Im-mersive Environments – is a large scale collaborative project co-funded by the European Commission targeting novel research in the general domain of Networked Media and Search Systems. The project aims to bring about a revolution in 3D media and virtual reality by developing technologies for safe,(More)
  • 1